Robert Baffi
Director/Board Member at MOSAIC IMMUNOENGINEERING, INC.
Net worth: - $ as of 30/03/2024
Profile
Robert A.
Baffi is currently serving as the Director at the National Institute for Bioprocessing Research & Training.
He is also currently holding positions as the Director at Neurogene, Inc., the Independent Director at Neurogene, Inc., the Director at Bionic Sight, Inc., the Independent Director at Mosaic ImmunoEngineering, Inc., and the Venture Partner at Samsara Biocapital LLC.
In his former roles, Dr. Baffi worked as the Director at Genentech, Inc. from 1986 to 2000.
He also served as the Director at Humanigen, Inc. from 2014 to 2015.
Additionally, he held the position of Executive Vice President-Technical Operations at BioMarin Pharmaceutical, Inc. from 2000 to 2020.
He also worked as a Research Scientist at Cooper Biomedical, Inc.Dr. Baffi completed his undergraduate, graduate, and doctorate degrees at City University of New York in 1983.
He also obtained an MBA from Regis University in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/02/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Robert Baffi active positions
| Companies | Position | Start |
|---|---|---|
| MOSAIC IMMUNOENGINEERING, INC. | Director/Board Member | 09/06/2021 |
National Institute for Bioprocessing Research & Training
 National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Director/Board Member | - |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Director/Board Member | 16/09/2020 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 28/02/2021 |
Former positions of Robert Baffi
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 03/05/2020 |
| HUMANIGEN, INC. | Director/Board Member | 19/11/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director/Board Member | 31/12/1999 |
Cooper Biomedical, Inc.
 Cooper Biomedical, Inc. Medical SpecialtiesHealth Technology Cooper Biomedical, Inc. manufactures and sells medical devices. The private company is based in Malvern, PA. | Corporate Officer/Principal | - |
Training of Robert Baffi
| City University of New York | Doctorate Degree |
| Regis University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| MOSAIC IMMUNOENGINEERING, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Health Technology |
Cooper Biomedical, Inc.
Cooper Biomedical, Inc. Medical SpecialtiesHealth Technology Cooper Biomedical, Inc. manufactures and sells medical devices. The private company is based in Malvern, PA. | Health Technology |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Robert Baffi
